View Older Stories View More Recent Stories

Feb 14, 2024 06:06AM Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies
Feb 13, 2024 04:16PM Form SC 13D/A PepGen Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 13, 2024 07:00AM ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
Feb 12, 2024 04:50PM Form SC 13D/A Mineralys Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 12, 2024 04:19PM Form SC 13G Corbus Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 12, 2024 04:18PM Form SC 13G Astria Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 8, 2024 08:04AM Mineralys Therapeutics (MLYS) Enters $120M Private Placement Financing at $13.50/sh
Feb 8, 2024 08:01AM Tenaya Therapeutics (TNYA) Prices 8.89M Share Offering at $4.50/sh
Feb 8, 2024 08:00AM Mineralys Therapeutics Announces $120 Million Private Placement Financing
Feb 8, 2024 08:00AM Tenaya Therapeutics Announces Pricing of Underwritten Offering
Feb 7, 2024 07:30AM PepGen (PEPG) Prices 7.53M Share Offering at $10.635/sh
Feb 7, 2024 07:30AM PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock
Feb 6, 2024 04:41PM Form SC 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 5, 2024 04:31PM Form SC 13G Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 5, 2024 08:00AM MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
Feb 2, 2024 08:02AM Tyra Biosciences (TYRA) Announces $200M Private Placement
Feb 2, 2024 08:00AM Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Feb 2, 2024 06:02AM Form SC 13G Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 1, 2024 09:00AM Be Biopharma to Present at the 20th Annual WORLDSymposium™ 2024
Jan 31, 2024 08:00AM MBX Biosciences to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
Jan 30, 2024 05:04PM Investors and Innovators Representing more than $309B in Biotech Assets and 624 New Drugs in Development Urge the Congressional Budget Office to Update its Drug R&D Policy Impact Model
Jan 30, 2024 05:04PM Investors and Innovators Representing more than $309B in Biotech Assets and 624 New Drugs in Development Urge the Congressional Budget Office to Update its Drug R&D Policy Impact Model
Jan 30, 2024 09:08AM Astria Therapeutics (ATXS) Prices 10.34M Share Offering at $12.09/sh
Jan 30, 2024 09:08AM Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
Jan 30, 2024 08:15AM Jnana Therapeutics Announces Positive Clinical Proof of Concept Achieved with JNT-517, a Potential First-in-Class Oral Treatment for PKU
Jan 29, 2024 04:31PM Form SC 13G Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 29, 2024 08:36AM New Company Eyconis Formed to Develop Ascendis Pharma (ASND) Ophthalmology Assets with $150 Million Commitment from External Investors
Jan 29, 2024 08:30AM New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million Commitment from External Investors
Jan 25, 2024 09:00AM Be Biopharma to Present at Keystone Symposia on Emerging Cellular Therapies
Jan 22, 2024 07:34AM Dianthus Therapeutics (DNTH) Announces $230 Million Private Placement of Common Stock, Warrants
Jan 22, 2024 07:30AM Dianthus Therapeutics Announces $230 Million Private Placement
Jan 19, 2024 04:31PM Form SC 13G Vaxart, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 19, 2024 08:38AM Edgewise Therapeutics (EWTX) Prices $240 Million Underwritten Offering of Common Stock
Jan 19, 2024 08:37AM Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock
Jan 17, 2024 08:05AM Day One Biopharmaceuticals (DAWN) Announces Two New Appointments to Board of Directors
Jan 17, 2024 08:00AM Day One Announces Two New Appointments to Board of Directors
Jan 16, 2024 09:25AM Vaxart (VXRT) Announces 15.38M Share Offering at $0.65/sh
Jan 16, 2024 09:25AM Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
Jan 12, 2024 05:01PM Form SC 13G Longboard Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 12, 2024 10:28AM San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry
Jan 11, 2024 05:25PM Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 10, 2024 02:30PM Commons Clinic Launches the Center for Spine Economics, Outcomes & Research to Pioneer Spinal Restoration Care Model
Jan 8, 2024 07:10AM Solid Biosciences (SLDB) Enters $108.9M Private Placement
Jan 8, 2024 07:09AM Solid Biosciences Announces $109 Million Private Placement
Jan 4, 2024 04:01PM Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization
Jan 4, 2024 08:00AM Jnana Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Jan 4, 2024 03:55AM GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry
Dec 29, 2023 04:31PM Form SC 13G UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 28, 2023 09:00AM Be Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 26, 2023 04:30PM Form SC 13G C4 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
View More Recent Stories View Older Stories